P14719
Gene name |
Il1rl1 (Ly84, St2, Ste2) |
Protein name |
Interleukin-1 receptor-like 1 |
Names |
Interleukin-33 receptor alpha chain, Lymphocyte antigen 84, Protein ST2, Protein T1 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:17082 |
EC number |
3.2.2.6: Hydrolyzing N-glycosyl compounds |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
2 structures for P14719
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 5VI4 | X-ray | 279 A | B/E | 26-326 | PDB |
| AF-P14719-F1 | Predicted | AlphaFoldDB |
33 variants for P14719
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs1133019593 | 5 | Q>R | No | EVA | |
| rs1133847496 | 16 | T>A | No | EVA | |
| rs1132357396 | 19 | M>V | No | EVA | |
| rs3388467130 | 35 | N>D | No | EVA | |
| rs260927391 | 44 | Q>K | No | EVA | |
| rs3388465063 | 69 | N>Y | No | EVA | |
| rs3388465058 | 131 | S>L | No | EVA | |
| rs260943543 | 192 | A>S | No | EVA | |
| rs51401641 | 192 | A>V | strain: C3H/He [UniProt] | No | EVA |
| rs3388465104 | 203 | T>N | No | EVA | |
| rs3388465503 | 252 | A>V | No | EVA | |
| rs3388465577 | 253 | D>G | No | EVA | |
| rs3388466604 | 261 | T>A | No | EVA | |
| rs3388466809 | 266 | F>C | No | EVA | |
| rs3388467076 | 266 | F>L | No | EVA | |
| rs1134458377 | 300 | K>Q | No | EVA | |
| rs3388466520 | 306 | Y>C | No | EVA | |
| rs3388466826 | 324 | R>S | No | EVA | |
| rs3388466198 | 338 | V>I | No | EVA | |
| rs3388467359 | 355 | L>F | No | EVA | |
| rs259636271 | 368 | D>G | No | EVA | |
| rs1133996513 | 376 | R>W | No | EVA | |
| rs214759597 | 400 | H>R | No | EVA | |
| rs47001137 | 413 | V>I | No | EVA | |
| rs3389887408 | 433 | Q>P | No | EVA | |
| rs52008393 | 445 | N>S | No | EVA | |
| rs252948089 | 460 | S>N | No | EVA | |
| rs3388465576 | 463 | F>V | No | EVA | |
| rs236413291 | 492 | E>K | No | EVA | |
| rs3388467540 | 493 | A>T | No | EVA | |
| rs3388466926 | 516 | K>E | No | EVA | |
| rs3388466399 | 532 | F>L | No | EVA | |
| rs261337760 | 549 | T>M | No | EVA |
No associated diseases with P14719
Functions
| Description | ||
|---|---|---|
| EC Number | 3.2.2.6 | Hydrolyzing N-glycosyl compounds |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
7 GO annotations of cellular component
| Name | Definition |
|---|---|
| cell surface | The external part of the cell wall and/or plasma membrane. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| external side of plasma membrane | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| focal adhesion | A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ). |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| interleukin-1 receptor activity | Combining with interleukin-1 to initiate a change in cell activity. Interleukin-1 is produced mainly by activated macrophages and is involved in the inflammatory response. |
| interleukin-33 binding | Binding to interleukin-33. |
| interleukin-33 receptor activity | Combining with interleukin-33 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| NAD(P)+ nucleosidase activity | Catalysis of the reaction: NAD(P)+ + H2O = ADP-ribose(P) + nicotinamide. |
| NAD+ nucleotidase, cyclic ADP-ribose generating | Catalysis of the reaction: NAD+ + H2O = nicotinamide + ADP-ribose that proceeds in a stepwise fashion by ADP-ribosyl cyclase activity followed by cyclic ADP-ribose hydrolase activity. |
7 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of cell population proliferation | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| negative regulation of interferon-gamma production | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| negative regulation of T-helper 1 type immune response | Any process that stops, prevents, or reduces the frequency, rate, or extent of a T-helper 1 type immune response. |
| positive regulation of chemokine production | Any process that activates or increases the frequency, rate, or extent of chemokine production. |
| positive regulation of inflammatory response | Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
| positive regulation of interleukin-5 production | Any process that activates or increases the frequency, rate, or extent of interleukin-5 production. |
| positive regulation of macrophage activation | Any process that stimulates, induces or increases the rate of macrophage activation. |
6 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P14778 | IL1R1 | Interleukin-1 receptor type 1 | Homo sapiens (Human) | PR |
| P27930 | IL1R2 | Interleukin-1 receptor type 2 | Homo sapiens (Human) | PR |
| Q9NPH3 | IL1RAP | Interleukin-1 receptor accessory protein | Homo sapiens (Human) | PR |
| Q61730 | Il1rap | Interleukin-1 receptor accessory protein | Mus musculus (Mouse) | PR |
| Q9Z2B1 | Il18rap | Interleukin-18 receptor accessory protein | Mus musculus (Mouse) | PR |
| P13504 | Il1r1 | Interleukin-1 receptor type 1 | Mus musculus (Mouse) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MIDRQRMGLW | ALAILTLPMY | LTVTEGSKSS | WGLENEALIV | RCPQRGRSTY | PVEWYYSDTN |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ESIPTQKRNR | IFVSRDRLKF | LPARVEDSGI | YACVIRSPNL | NKTGYLNVTI | HKKPPSCNIP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| DYLMYSTVRG | SDKNFKITCP | TIDLYNWTAP | VQWFKNCKAL | QEPRFRAHRS | YLFIDNVTHD |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DEGDYTCQFT | HAENGTNYIV | TATRSFTVEE | KGFSMFPVIT | NPPYNHTMEV | EIGKPASIAC |
| 250 | 260 | 270 | 280 | 290 | 300 |
| SACFGKGSHF | LADVLWQINK | TVVGNFGEAR | IQEEEGRNES | SSNDMDCLTS | VLRITGVTEK |
| 310 | 320 | 330 | 340 | 350 | 360 |
| DLSLEYDCLA | LNLHGMIRHT | IRLRRKQPID | HRSIYYIVAG | CSLLLMFINV | LVIVLKVFWI |
| 370 | 380 | 390 | 400 | 410 | 420 |
| EVALFWRDIV | TPYKTRNDGK | LYDAYIIYPR | VFRGSAAGTH | SVEYFVHHTL | PDVLENKCGY |
| 430 | 440 | 450 | 460 | 470 | 480 |
| KLCIYGRDLL | PGQDAATVVE | SSIQNSRRQV | FVLAPHMMHS | KEFAYEQEIA | LHSALIQNNS |
| 490 | 500 | 510 | 520 | 530 | 540 |
| KVILIEMEPL | GEASRLQVGD | LQDSLQHLVK | IQGTIKWRED | HVADKQSLSS | KFWKHVRYQM |
| 550 | 560 | ||||
| PVPERASKTA | SVAAPLSGKA | CLDLKHF |